You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ART first-line failure

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Option B+: Study on Safety, Viral Suppression, and Survival on

Completed
  • HIV
  • Infant Exposure to Efavirenz
    • Lilongwe, Malawi
      UNC Project Malawi
    Mar 10, 2021

    Local Progression or Metastatic Melanoma With Failed First-line Treatment Trial in Beijing (Pexa-Vec combined with ZKAB001,

    Recruiting
    • Local Progression or Metastatic Melanoma With Failed First-line Treatment
    • Pexa-Vec combined with ZKAB001
    • ZKAB001 monotherapy
    • Beijing, China
      Beijing Cancer Hospital
    Mar 30, 2022

    Non Small Cell Lung Cancer Metastatic Trial in France (Lorlatinib)

    Recruiting
    • Non Small Cell Lung Cancer Metastatic
    • Angers, France
    • +31 more
    Apr 12, 2022

    Factors of PD-1 Therapeutic Efficacy in Advanced Pancreatic

    Recruiting
    • Pancreatic Ductal Adenocarcinoma, PDAC
      • Shanghai, Shanghai, China
        Ruijin Hospital
      Jan 24, 2022

      HIV/AIDS Trial in Elandsdoorn (Intensified monitoring, Standard of care monitoring)

      Completed
      • HIV/AIDS
      • Intensified monitoring
      • Standard of care monitoring
      • Elandsdoorn, Limpopo, South Africa
        Ndlovu Medical Centre
      May 10, 2022

      Advanced NSCLC Trial in China (Gene Profile explore)

      Recruiting
      • Advanced NSCLC
      • Gene Profile explore
      • Beijing, China
      • +14 more
      Jan 27, 2023

      Intrahepatic Cholangiocarcinoma Trial (Famitinib)

      Withdrawn
      • Intrahepatic Cholangiocarcinoma
      • (no location specified)
      Jun 16, 2021

      Non Small Cell Lung Cancer Metastatic Trial in France (Lorlatinib)

      Recruiting
      • Non Small Cell Lung Cancer Metastatic
      • Aix-en-Provence, France
      • +38 more
      Aug 9, 2022

      HIV-1-infection Trial (Cabotegravir/Rilpivirine, Antiretroviral)

      Recruiting
      • HIV-1-infection
      • Kisumu, Kenya
      • +6 more
      Feb 1, 2023

      HIV, AIDS, Virologic Failure Trial (Maintenance on TLD treatment strategy, Individualized Care treatment strategy, Immediate

      Not yet recruiting
      • HIV Infections
      • +2 more
      • Maintenance on TLD treatment strategy
      • +2 more
      • (no location specified)
      May 9, 2022

      Nonsquamous NSCLC Trial in Yichang (Sintilimab, Docetaxel, Pemetrexed)

      Recruiting
      • Nonsquamous Non-Small Cell Lung Cancer
      • Yichang, Hubei, China
        Department of Medical Oncology, Central Hospital of Yichang City
      Nov 5, 2021

      Nonsquamous NSCLC Trial in Yichang (Sintilimab, Docetaxel, Pemetrexed)

      Recruiting
      • Nonsquamous Non-Small Cell Lung Cancer
      • Yichang, Hubei, China
        Department of Medical Oncology, Central Hospital of Yichang City
      Nov 5, 2021

      Decision-making of ctDNA in mCRC After Failure of First-line

      Not yet recruiting
      • Metastatic Colorectal Cancer
      • Cetuximab Ab; Bevacizumab; Vermofenib + cetuximab;Trastuzumab+lapatinib or trastuzumab+pertuzumab; others
      • (no location specified)
      Apr 2, 2021

      Esophageal Squamous Cell Carcinoma Trial in Beijing (IBI308, paclitaxel/ irinotecan)

      Completed
      Has Results
      • Esophageal Squamous Cell Carcinoma
      • IBI308
      • paclitaxel/ irinotecan
      • Beijing, Beijing, China
        The Fifth Medical Center of PLA Ceneral Hospital
      Jan 17, 2021

      Soft Tissue Sarcoma Trial in Zhengzhou (Albumin-Bound Paclitaxel, Camrelizumab)

      Recruiting
      • Soft Tissue Sarcoma
      • Zhengzhou, Henan, China
        Department of Bone and Soft Tissue, Henan Cancer Hospital
      Jan 13, 2022

      HIV Trial (Same-day ART initiation [experimental], Standard ART initiation [usual care], Community-based HIV care

      Not yet recruiting
      • HIV Infections
      • Same-day ART initiation [experimental]
      • +5 more
      • (no location specified)
      Aug 9, 2022

      Cervical Cancer Trial (BAVC-C+Durvalumab)

      Not yet recruiting
      • Cervical Cancer
      • BAVC-C+Durvalumab
      • (no location specified)
      Mar 14, 2021

      Colorectal Tumors, Liver Tumors Trial in La Jolla, San Diego (Yttrium-90 Radioactive Resin Microspheres)

      Terminated
      Has Results
      • Colorectal Neoplasms
      • Liver Neoplasms
      • Yttrium-90 Radioactive Resin Microspheres
      • La Jolla, California
      • +1 more
      Aug 2, 2021

      HIV Infection Trial in Worldwide (DTG)

      Active, not recruiting
      • HIV Infection
      • Frankfurt, Germany
      • +27 more
      Apr 27, 2021

      Emergence of HIV Drug Resistance Following Initiation of TLD

      Recruiting
      • HIV-1-infection
        • Port-au-Prince, Bicentaire, Haiti
        • +13 more
        Feb 22, 2022

        HIV, Clinical Outcomes, Adverse Drug Event Trial in Salvador, São Paulo (No intervention)

        Recruiting
        • HIV Infections
        • +3 more
        • No intervention
        • Salvador, Bahia, Brazil
        • +2 more
        Mar 15, 2022

        Contributing Factors for Poor HIV Treatment Response in TB/HIV

        Recruiting
        • Tuberculosis
        • +2 more
        • Observational study
        • Kumasi, Ghana
          Kwame Nkrumah University of Science and Technology
        Mar 23, 2022

        HIV A6 Genome In ART Unsuccessful Patients On DOR

        Not yet recruiting
        • Virus-HIV
        • (no location specified)
        Apr 4, 2022

        Acquired Pure Red Cell Aplasia Trial in Tianjin (bortezomib/dexamethasone)

        Recruiting
        • Acquired Pure Red Cell Aplasia
        • Tianjin, China
          Regenerative Medicine Center
        Sep 13, 2020

        Extensive Stage Small Cell Lung Cancer Trial in Fuzhou (Fluzoparil, Anlotinib)

        Not yet recruiting
        • Extensive Stage Small Cell Lung Cancer
        • Fuzhou, Fujain, China
          Liu Zhenhua. ZhuangWu
        Jun 17, 2021